Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Sacred Stories Project to Amplify Christian Vocational Narratives

globenewswire.com
LLY

Rise of Direct-to-Patient GLP-1 Sales Shakes Up Care Models, HCPs Split on Pharma’s Expanding Role

businesswire.com
LLY NVO

Peptide Therapeutics Market Size to Surpass USD 87.21 Billion by 2035 Driven by Rising Cancer, Diabetes, and Demand for Targeted Therapies

globenewswire.com
LLY AMGN PFE

Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

prnewswire.com
LLY

Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia

globenewswire.com
LLY

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight

prnewswire.com
ABBV JNJ LLY MRK PFE ABVX

Levin Papantonio - Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION)

globenewswire.com
LLY

BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
PFE SNY TSEM JNJ LLY MRK BMY ABBV GILD CRSP NKTR INCY

Drug Delivery Devices Market Set to Exceed US$ 450.7 Billion by 2035 as Biologic Revenue Surges Drive Urgent Expansion of Device Manufacturing Capacity Says Astute Analytica

globenewswire.com
LLY NVO BDX WST STZ

Breast Cancer Drugs Market to Reach USD 57.1 Billion by 2031 as Precision Oncology and Targeted Therapies Redefine Treatment Outcomes

prnewswire.com
NVS LLY AZN MRK ABBV BMED MGNX